Amlodipine Dosing and Side Effects
Initial Dosing
Start amlodipine at 5 mg once daily for most adults with hypertension or coronary artery disease, with a lower starting dose of 2.5 mg once daily reserved for small, fragile, elderly patients, or those with hepatic insufficiency. 1
- The FDA-approved initial dose is 5 mg once daily, which can be titrated to a maximum of 10 mg once daily 1
- For pediatric patients ages 6-17 years, start at 2.5 mg once daily with a maximum of 5 mg once daily 1
- Amlodipine can be administered at any time of day to improve adherence 2
Dose Titration Algorithm
Wait 7 to 14 days between dose escalation steps under normal circumstances, but titrate more rapidly if clinically warranted with frequent patient assessment. 1
- Increase from 5 mg to 10 mg once daily if blood pressure remains ≥130/80 mmHg after 2-6 weeks of treatment 2
- Before escalating the dose, confirm inadequate control with home blood pressure monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) 2
- Check medication adherence before dose escalation, as non-adherence is the most common cause of apparent treatment failure 2
- Measure blood pressure at trough (just before the next dose) to ensure true 24-hour control 2
Combination Therapy Strategy
Consider adding a second antihypertensive agent rather than maximizing amlodipine to 10 mg if blood pressure control is inadequate after 4-6 weeks at 5 mg. 2
- Preferred combinations include amlodipine + ACE inhibitor/ARB or amlodipine + thiazide-type diuretic 2
- For black adults with hypertension, initial treatment should include a thiazide-type diuretic or calcium channel blocker like amlodipine 2
- Fixed-dose single-pill combinations are recommended when using combination therapy 2
Special Populations
Elderly Patients
- Start at 2.5 mg once daily due to 40-60% increase in drug exposure from decreased clearance 1
- Titrate cautiously with increased monitoring for orthostatic hypotension, falls, and syncope 3
Hepatic Impairment
- Start at 2.5 mg once daily due to 40-60% increase in AUC from decreased hepatic clearance 1
- For chronic stable or vasospastic angina in hepatic insufficiency, use the lower end of the 5-10 mg dose range 1
Renal Impairment
- No dose adjustment required regardless of severity of renal impairment 2, 1
- Amlodipine has minimal renal clearance (7 mL/min/mg) and demonstrates renoprotective effects 2
Coronary Artery Disease
- The recommended dose range is 5-10 mg once daily, with most patients requiring 10 mg for adequate effect 1
- Long-acting calcium channel blockers like amlodipine are preferred for vasospastic angina 3
Common Side Effects
The most common dose-dependent side effect is peripheral edema, occurring in 1.8% at 2.5 mg, 3.0% at 5 mg, and 10.8% at 10 mg daily. 1
Dose-Related Side Effects (incidence increases with higher doses):
- Peripheral edema: 1.8% (2.5 mg) → 3.0% (5 mg) → 10.8% (10 mg) 1
- Palpitations: 0.7% (2.5 mg) → 1.4% (5 mg) → 4.5% (10 mg) 1
- Flushing: 0.7% (2.5 mg) → 1.4% (5 mg) → 2.6% (10 mg) 1
- Dizziness: 1.1% (2.5 mg) → 3.4% (5 mg) → 3.4% (10 mg) 1
Non-Dose-Related Side Effects (>1% incidence):
Gender Differences in Side Effects
Women experience significantly higher rates of edema (14.6% vs 5.6% in men), flushing (4.5% vs 1.5%), and palpitations (3.3% vs 1.4%). 1
Serious but Rare Side Effects (<1%):
- Arrhythmias (including ventricular tachycardia and atrial fibrillation) 1
- Bradycardia, syncope 1
- Angioedema, erythema multiforme 1
- Gingival hyperplasia 1
- Gynecomastia (postmarketing) 1
Important Drug Interactions
CYP3A4 Inhibitors
- Strong CYP3A4 inhibitors (itraconazole, clarithromycin) may significantly increase amlodipine levels 1
- Diltiazem 180 mg daily increases amlodipine exposure by 60% 1
Drugs Affected by Amlodipine
- Simvastatin: 77% increase in exposure when co-administered with amlodipine 10 mg; consider lower simvastatin doses 1
- Cyclosporine: Average 40% increase in trough levels 1
- Tacrolimus: 2.5-4 fold increase in exposure in CYP3A5 expressers; monitor levels closely regardless of genotype 1
Clinical Pearls
- Amlodipine has a long half-life of 30-50 hours, providing true 24-hour blood pressure control with once-daily dosing 1, 5
- Steady-state plasma levels are reached after 7-8 days of consecutive daily dosing 1
- Discontinuation due to adverse effects occurs in only 1.5% of patients, similar to placebo 1
- The ALLHAT trial demonstrated that amlodipine was equally effective as chlorthalidone for primary cardiovascular outcomes, though it showed a 38% increase in heart failure compared to diuretic therapy 3
- Schedule monthly visits until blood pressure target is achieved, then transition to 90-day refills when possible 2